Frequency of hepatitis B and hepatitis C in patients with hepatocellular carcinoma at hyderabad

Journal of the Liaquat University of Medical and Health Sciences

Volumn 8, Issue 2, 2009, Pages 109-112

  Ansari, Shoaib ^a   Memon, Muhammad Sadik ^b   Devrajani, Bikha Ram ^a  

^a LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES   (Pakistan)

^b ISRA UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Alcohol; Cirrhosis; Hepatitis B; Hepatitis C; Hepatocellular carcinoma

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PREVALENCE; SEROLOGY;

EID: 76749116197     PISSN: 17290341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bosch FX, Ribes J, Diaz M. Primary liver cancer; worldwide incidence and trends. Gastroenterology Nov 2004; 127(5 suppl 1):S5-S16.
2. Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 2007;96:1127-34.
3. th ed. Philadelphia: Lipincott Williams and Wilkins; 2008.
4. Chuang SG, Vecchia CL, Boffetta P. Liver Cancer. Descriptive epidemiology and risk factor other than HBV and HCV infection. Cancer Lett 2008;
5. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B. Lancet 1981;2:1129-33.
6. Colombo M, Kuo G, Choo Q. Prevalence of antibodies to hepatitis C virus in Italian patients with Hepatocellular carcinoma. Lancet 1989;2:1006-8.
7. Kenneth W, Lin, Jeffrey T Kirchner. Hepatitis B. Am Fam Physician 2004;69:75-82.
8. Befler AS, Di Bisceglie AM. Hepatitis B. Infect Dis Clin North Am 2000;14:617-32.
9. WHO and the Viral Hepatitis Prevention Board. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6:35-47..
10. EL Serag HB. Hepatocellular carcinoma and hepatitis C in the united states. Hepatol 2002; 36 (5 suppl 1): S74-83.
11. Hamid S, Umar M, Alam A. Consensus statement on management of Hepatitis C virus infection 2003. J Pak Med Assoc 2004;54:146-50.
12. Rehman AlU, Murad S. Hepatocellular carcinoma: a retrospective analysis of 118 cases. J Coll Physicians Surg Pak 2002;12:108-9.
13. Lu SN, Su WW, Yang SS, Chang TT, Cheng KS, Wu JC, et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 2006;119:1946-52.
14. Parkin DM. The global health burden of infectionassociated cancers in the year 2002. Int J Cancer 2006;118:3030-44.
15. Khokhar N, Aijazi I, Gill ML. Spectrum of Hepatocellular Carcinoma at Shifa International Hospital Islamabad. J Ayoub Med Coll Abottabad Oct - Dec 2003;15(4):1-4.
16. Sharif S, Burney I, Abdul Salam, Siddiqui T. Hepatocellular carcinoma. J Coll Physicians Surg Pak May 2002;12(5):264-7.
17. Lehman EM, Wilson ML. Epidemiology of hepatitis virus among hepatocellular carcinoma cases and healthy people in Egypt; a systemic review and meta analysis. Int J cancer 2009 Feb 1;124 (3):690-7.
18. Amin J, Yousif H, Mumtaz A. Prevalence of Hepatitis B Surface antigen and Anti Hepatitis C virus. Professional Med J 2004; 11(3):334-7.
19. Michelson PP, Francque SM, Van Dongen JL. Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol 2005; 3:27.
20. Yuen MF, Tanaka Y, Fong DY. Independent risk factor and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol 2009; 50(1):80-8.
21. Por A. Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma. Ory Hetil 2009; 150(1):19-26.
22. Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Serum Oncol 2001; 28(5):441-9.
23. Goeser T, Muller HM, Solbach C, Toe U. Hepatitis C Virus, alcoholic cirrhosis and hepaocellular carcinoma. Cancer epidemiol Biomarkers Prev 1994; 3(4):311-5.